6,406 Followers on Owler

Moderna

Read more
Stephane Bancel's photo - CEO of Moderna

CEO

Stephane Bancel

CEO Approval Rating

74/100

Founded:

2010

Status:

PublicIndependent CompanyNASDAQMRNA

Moderna Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$7B

Moderna's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 15.8B. Over the last four quarters, Moderna's revenue has grown by 2657.3%. Specifically, in Q2 2021's revenue was $4.4B; in Q1 2021, it was $1.9B; in Q4 2020, it was $570.5M; in Q3 2020, Moderna's revenue was $157.9M.

Moderna News

Moderna Press Releases

Moderna Videos

Social Media

Moderna Headquarters

200 Technology Square

Cambridge, Massachusetts02139

1-617-714-6500

Driving Directions »

Moderna Summary

ABOUT

Overview

Moderna is a biotechnology company that researches & markets mRNA therapeutics for genetic disorders, oncology treatments & a COVID-19 vaccine. Moderna was founded in 2010. Moderna's headquarters is located in Cambridge, Massachusetts, USA 02139. It ...

CEO

Moderna's CEO, Stephane Bancel, currently has an approval rating of 74%. Moderna's primary competitors are Pfizer, AstraZeneca & BioNTech.

Acquisitions

There have been no acquisitions found related to Moderna

Frequently Asked Questions about Moderna

  1. When was Moderna founded?

    Moderna was founded in 2010
  2. Who is Moderna's CEO?

    Moderna's CEO is Stephane Bancel
  3. How much revenue does Moderna generate?

    Moderna generates $7B in revenue
  4. How much funding does Moderna have?

    Moderna has historically raised $3.6B in funding
  5. Where is Moderna's headquarters?

    Moderna's headquarters is in Cambridge Massachusetts, USA
  1. How many employees does Moderna have?

    Moderna has 760 employees
  2. What sector does Moderna operate in?

    Moderna is in Biotechnology
  3. Who are Moderna's competitors?

    Moderna's top competitors are Pfizer, AstraZeneca, BioNTech
  4. Who has Moderna invested in?

    Moderna's has invested in companies such as Onkaido Therapeutics

Trending Companies